{
  "ticker": "GILD",
  "last_updated": "2025-04-19T10:04:54.704574",
  "retention_years": 3,
  "count": 591,
  "transactions": [
    {
      "id": 391522,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-04-15",
      "transaction_shares": "2500",
      "transaction_price": "106.40",
      "transaction_type": "S",
      "shares_after_transaction": "168174"
    },
    {
      "id": 344098,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-17",
      "transaction_shares": "2500",
      "transaction_price": "110.53",
      "transaction_type": "S",
      "shares_after_transaction": "170674"
    },
    {
      "id": 391534,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-17",
      "transaction_shares": "2500",
      "transaction_price": "110.53",
      "transaction_type": "S",
      "shares_after_transaction": "170674"
    },
    {
      "id": 344077,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-03-10",
      "transaction_shares": "1952",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40077"
    },
    {
      "id": 344079,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "24024",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "641900"
    },
    {
      "id": 344106,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "3343",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37692"
    },
    {
      "id": 344111,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "4916",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "173977"
    },
    {
      "id": 344151,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "8080",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "128059"
    },
    {
      "id": 391512,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-03-10",
      "transaction_shares": "1952",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40077"
    },
    {
      "id": 391514,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "24024",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "641900"
    },
    {
      "id": 391542,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "3343",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37692"
    },
    {
      "id": 391547,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "4916",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "173977"
    },
    {
      "id": 391587,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "8080",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "128059"
    },
    {
      "id": 299150,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-18",
      "transaction_shares": "2500",
      "transaction_price": "104.09",
      "transaction_type": "S",
      "shares_after_transaction": "169061"
    },
    {
      "id": 344147,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-18",
      "transaction_shares": "2500",
      "transaction_price": "104.09",
      "transaction_type": "S",
      "shares_after_transaction": "169061"
    },
    {
      "id": 391583,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-18",
      "transaction_shares": "2500",
      "transaction_price": "104.09",
      "transaction_type": "S",
      "shares_after_transaction": "169061"
    },
    {
      "id": 299104,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "77691",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "248914"
    },
    {
      "id": 344099,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "77691",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "248914"
    },
    {
      "id": 391535,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "77691",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "248914"
    },
    {
      "id": 299108,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-02-04",
      "transaction_shares": "709",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37787"
    },
    {
      "id": 299114,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "60031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "561559"
    },
    {
      "id": 299130,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "94933"
    },
    {
      "id": 299138,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149666"
    },
    {
      "id": 299155,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12371",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34011"
    },
    {
      "id": 344103,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-02-04",
      "transaction_shares": "709",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37787"
    },
    {
      "id": 344110,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "60031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "561559"
    },
    {
      "id": 344127,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "94933"
    },
    {
      "id": 344135,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149666"
    },
    {
      "id": 344153,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12371",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34011"
    },
    {
      "id": 391539,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-02-04",
      "transaction_shares": "709",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37787"
    },
    {
      "id": 391546,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "60031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "561559"
    },
    {
      "id": 391563,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "94933"
    },
    {
      "id": 391571,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149666"
    },
    {
      "id": 391589,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12371",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34011"
    },
    {
      "id": 299103,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "26170",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156043"
    },
    {
      "id": 344097,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "26170",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156043"
    },
    {
      "id": 391533,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "26170",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156043"
    },
    {
      "id": 258709,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 299128,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 344125,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 391561,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 258714,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 299134,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 344131,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 391567,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 223444,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 258712,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 299132,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 344129,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 391565,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 223405,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 223408,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 223417,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 223427,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 223434,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 223441,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 258672,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 258675,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 258684,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 258694,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 258701,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 258708,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 299086,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 299090,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 299099,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 299112,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 299120,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 299127,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 344078,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 344083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 344093,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 344108,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 344117,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 344124,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 391513,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 391518,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 391529,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 391544,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 391553,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 391560,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 223457,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 258726,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 299147,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 344144,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 391580,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 223436,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 258703,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 299122,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 344119,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 391555,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 190811,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 223402,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 258669,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 299083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 344074,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 391509,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 190846,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 190850,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 223447,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 223452,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 258716,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 258721,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 299136,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 299142,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 344133,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 344139,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 391569,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 391575,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 160589,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 190824,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 223418,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 258685,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 299100,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 344094,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 391530,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 160603,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 190838,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 223433,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 258700,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 299119,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 344116,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 391552,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 132717,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 132742,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 160578,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 160605,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 190813,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 190840,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 223404,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 223437,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 258671,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 258704,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 299085,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 299123,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 344076,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 344120,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 391511,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 391556,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 132718,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 132731,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 132733,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 132741,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 132743,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 132745,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 160579,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 160593,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 160595,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 160604,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 160606,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 160608,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 190814,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 190828,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 190830,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 190839,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 190841,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 190843,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 223406,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 223422,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 223424,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 223435,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 223439,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 223442,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 258673,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 258689,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 258691,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 258702,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 258706,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 258710,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 299088,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 299106,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 299109,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 299121,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 299125,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 299129,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 344081,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 344101,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 344104,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 344118,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 344122,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 344126,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 391516,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 391537,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 391540,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 391554,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 391558,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 391562,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 132726,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 160587,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 190822,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 223415,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 258682,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 299097,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 344091,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 391527,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 106837,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 132747,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 160610,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 190845,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 223445,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 258713,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 299133,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 344130,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 391566,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 106842,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 132752,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 160615,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 190852,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 223454,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 258723,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 299144,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 344141,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 391577,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 82894,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 106833,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 132739,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 160601,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 190836,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 223431,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 258698,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 299117,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 344114,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 391550,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 82890,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 106829,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 132735,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 160597,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 190832,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 223426,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 258693,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 299111,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 344107,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 391543,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 61286,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 61290,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 61296,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 61301,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 61304,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 61306,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 82878,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 82882,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 82888,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 82895,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 82898,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 82900,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 106817,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 106821,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 106827,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 106834,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 106838,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 106840,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 132720,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 132724,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 132732,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 132740,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 132748,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 132750,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 160581,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 160585,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 160594,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 160602,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 160611,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 160613,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 190816,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 190820,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 190829,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 190837,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 190847,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 190849,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 223409,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 223413,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 223423,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 223432,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 223448,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 223451,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 258676,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 258680,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 258690,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 258699,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 258717,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 258720,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 299091,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 299095,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 299107,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 299118,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 299137,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 299141,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 344084,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 344089,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 344102,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 344115,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 344134,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 344138,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 391519,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 391525,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 391538,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 391551,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 391570,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 391574,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 41963,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 41966,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 41971,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 41972,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 41984,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 61282,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 61285,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 61292,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 61293,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 61310,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 82874,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 82877,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 82884,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 82885,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 82904,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 106813,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 106816,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 106823,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 106824,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 106845,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 132714,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 132719,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 132727,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 132728,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 132755,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 160575,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 160580,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 160588,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 160590,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 160618,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 190809,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 190815,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 190823,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 190825,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 190855,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 223400,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 223407,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 223416,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 223419,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 223458,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 258667,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 258674,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 258683,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 258686,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 258727,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 299081,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 299089,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 299098,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 299101,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 299148,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 344072,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 344082,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 344092,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 344095,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 344145,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 391507,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 391517,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 391528,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 391531,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 391581,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 41979,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 61303,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 82897,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 106836,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 132746,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 160609,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 190844,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 223443,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 258711,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 299131,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 344128,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 391564,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 25652,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 41967,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 61287,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 82879,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 106818,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 132721,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 160582,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 190817,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 223410,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 258677,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 299092,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 344085,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 391520,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 13074,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 13077,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 13079,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 13083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 13085,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 13089,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 25650,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 25654,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 25656,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 25660,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 25663,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 25667,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 41962,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 41969,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 41973,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 41978,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 41982,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 41988,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 61281,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 61289,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 61294,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 61302,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 61308,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 61314,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 82873,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 82881,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 82886,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 82896,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 82902,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 82908,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 106812,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 106820,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 106825,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 106835,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 106843,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 106849,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 132713,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 132723,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 132729,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 132744,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 132753,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 132759,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 160574,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 160584,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 160591,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 160607,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 160616,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 160622,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 190808,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 190819,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 190826,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 190842,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 190853,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 190859,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 223399,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 223412,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 223420,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 223440,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 223455,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 223462,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 258666,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 258679,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 258687,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 258707,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 258724,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 258732,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 299080,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 299094,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 299102,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 299126,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 299145,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 299154,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 344071,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 344088,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 344096,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 344123,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 344142,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 344152,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 391506,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 391524,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 391532,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 391559,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 391578,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 391588,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 13087,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 25665,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 41986,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 61312,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 82906,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 106847,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 132757,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 160620,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 190857,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 223460,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 258730,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 299152,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 344149,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 391585,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 3948,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 13075,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 25651,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 41964,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 61283,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 82875,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 106814,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 132715,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 160576,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 190810,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 223401,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 258668,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 299082,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 344073,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 391508,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 3949,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 3951,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 3952,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 3953,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 3954,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 13076,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 13080,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 13081,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 13082,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 13084,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 25653,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 25657,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 25658,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 25659,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 25662,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 41968,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 41974,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 41976,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 41977,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 41981,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 61288,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 61295,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 61299,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 61300,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 61307,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 82880,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 82887,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 82892,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 82893,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 82901,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 106819,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 106826,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 106831,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 106832,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 106841,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 132722,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 132730,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 132737,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 132738,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 132751,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 160583,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 160592,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 160599,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 160600,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 160614,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 190818,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 190827,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 190834,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 190835,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 190851,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 223411,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 223421,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 223429,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 223430,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 223453,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 258678,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 258688,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 258696,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 258697,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 258722,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 299093,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 299105,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 299115,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 299116,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 299143,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 344086,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 344100,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 344112,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 344113,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 344140,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 391521,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 391536,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 391548,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 391549,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 391576,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 3950,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 13078,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 25655,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 41970,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 61291,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 82883,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 106822,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 132725,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 160586,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 190821,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 223414,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 258681,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 299096,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 344090,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 391526,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 223446,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-12-13",
      "transaction_shares": "181",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37259"
    },
    {
      "id": 258715,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-12-13",
      "transaction_shares": "181",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37259"
    },
    {
      "id": 299135,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-12-13",
      "transaction_shares": "181",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37259"
    },
    {
      "id": 344132,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-12-13",
      "transaction_shares": "181",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37259"
    },
    {
      "id": 391568,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-12-13",
      "transaction_shares": "181",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37259"
    }
  ]
}